If you compare the histological appearance of glioblastoma specimens from the first resection and from recurrence, is there any difference? If so, are there any publications describing this?
Brat DJ, Ryken TC, Kalkanis SN, Olson JJ; AANS/CNS Joint Guidelines Committee. The role of neuropathology in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2014 Jul;118(3):461-78. doi: 10.1007/s11060-013-1331-z.
If you would like to investigate this relationship, you can look at histology slides obtained from patients who participated in The Cancer Imaging Archive TCIA. http://cancer.digitalslidearchive.net/. Make sure to select the GBM cohort. However, there are only a few matched primary and recurrent samples.
It is possible to find some differences in some cases, but this is true only for a minority of patients. GBM can appear really "ugly" (I mean anaplastic) from the beginning.